EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

288 Role of Aprepitant in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Nameer Faiz, Ali MohamedAhmed, Mohamed Issa, Salma Mohammed

British Journal of Surgery · 29.12.2025 · 112 (Supplement_17)

DOI: 10.1093/bjs/znaf270.221 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 29.12.2025. Verfasst von Nameer Faiz und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Is to investigate the role of Aprepitant in prevention of postoperative nausea and vomiting post LSG.

Method

A systematic online search was conducted using electronic databases. Comparative studies of Aprepitant (AP) versus No-Aprepitant (NAP) for preventing nausea and vomiting post-LSG were included. The primary outcome was vomiting in the first two hours and 24 hours post-LSG. The requirement of rescue anti-emetics during the first two and 24 hours were the evaluated secondary outcome parameters. The meta-analysis was performed using Rev Man version 5.3.

Results

Three studies with a total number of 812 patients were eligible to be included in this review; 408 patients received AP, and 404 patients were allocated to the NAP group. The AP group showed a significantly lower risk for postoperative vomiting at 2 and 24 hours [3% in the AP group vs 7% in the NAP group, Risk ratio (RR) 0.44, P-value = 0.04] and [4.7% in the AP group vs 14.4% in the NAP group (RR 0.33, P-value = 0.0001), respectively. Regarding rescue antiemetics, the NAP group showed a higher requirement for rescue antiemetics compared to the AP group at two hours [27.8% in the AP group vs 41.6% in the NAP group, RR 0.54, P-value = 0.002] and at 24 hours [4.7% in the AP group vs 14.9% in the NAP group, RR 0.20, P-value = 0.0001].

Conclusions

Aprepitant provides excellent control of nausea and vomiting post-LSG. It decreases vomiting episodes and the requirement for further doses of anti-emetics, leading to better patient outcomes and satisfaction.

Zitieren

APA

Faiz, N., MohamedAhmed, A., Issa, M., & Mohammed, S. (2025). 288 Role of Aprepitant in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. British Journal of Surgery, 112(Supplement_17). https://doi.org/10.1093/bjs/znaf270.221

Vancouver

Faiz N, MohamedAhmed A, Issa M, Mohammed S. 288 Role of Aprepitant in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. British Journal of Surgery. 2025;112(Supplement_17). doi:10.1093/bjs/znaf270.221

BibTeX
@article{Faiz2025,
  author = {Faiz, Nameer and MohamedAhmed, Ali and Issa, Mohamed and Mohammed, Salma},
  title = {288 Role of Aprepitant in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials},
  journal = {British Journal of Surgery},
  year = {2025},
  volume = {112},
  number = {Supplement_17},
  doi = {10.1093/bjs/znaf270.221}
}
Kostenlos starten →